Public-registry trials using Placebo matching Apremilast that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.
| Trial | Sponsor | Condition | Phase | Sites |
| HPP737 in Adult Patients With Plaque Psoriasis | Newsoara Biopharma Co., Ltd. | Psoriasis | PHASE3 | 60 |
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →